WuXi XDC Aims for HKEX Listing with IPO of 178.4 Million Shares
WuXi XDC (HKG: 2268), a joint venture between Wuxi Biologics (HKG: 2269) and WuXi STA,...
CRO / CMO / CDMO
Resolian Expands Global Reach with Acquisition of China-Based Denali Medpharma
US-based bioanalytical contract research organization (CRO) Resolian has announced the acquisition of China-based CRO Denali...
Strategic Alliance Formed by uBriGene, Fraserna, and Virogin for Cell and Gene Therapy Services
In a significant move to bolster the cell and gene therapy (CGT) sector, China-based biotechnology...
Shanghai Pharmaceuticals Partners with Asymchem for Advanced Drug Development and Production
China-based pharmaceutical distribution giant Shanghai Pharmaceuticals (SPH; HKG: 2607; SHA: 601607) has entered into a...
Foundation Medicine Expands Genomic Profiling Partnership with Sequanta Technologies in China
US-based Contract Research Organization (CRO) Foundation Medicine Inc. has announced the expansion of its existing...
WuXi XDC Partners with Hong Kong Science Park to Boost CRDMO Value Chain
WuXi XDC, a joint venture between Wuxi Biologics (HKG: 2269) and WuXi STA, a subsidiary...
Pharmaron Beijing to Establish Singapore JV Rxilient Biohub for CDMO Services
China-based Contract Development and Manufacturing Organization (CDMO) Pharmaron Beijing Co., Ltd (HKG: 3759, SHE: 300759)...
Merck KGaA Partners with Porton Pharma for Next-Gen ADC Platform Development
German pharmaceutical giant Merck KGaA (ETR: MRK) has entered into a strategic partnership with China-based...
WuXi Biologics Launches WuXiUI: A Revolutionary Biotech Patent Platform
China-based Contract Research, Development, and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) has announced the...
BMS Expands CAR-T Collaboration with Cellares on Automation Tech
Bristol-Myers Squibb (BMS; NYSE: BMY) has entered into a technology transfer agreement with US-based Cellares,...
Apeloa Pharmaceutical Expands Global Footprint with Apeloa Europe GmbH in Germany
China-based contract development and manufacturing organization (CDMO) Apeloa Pharmaceutical Co., Ltd (SHE: 000739) has announced...
ZhenGe Biotech Partners with Glyco-Therapy to Develop Antibody Drug Conjugate Platform
China-based Contract Development and Manufacturing Organization (CDMO) ZhenGe Biotech has announced a strategic partnership with...
Chime Biologics Partners with Panolos Bioscience to Speed Up Multi-Specific Protein Development
China-based Contract Development and Manufacturing Organization (CDMO) Chime Biologics Ltd has announced a strategic cooperation...
WuXi XDC Expands Manufacturing Capacity with New GMP Facilities in Wuxi
WuXi XDC (HKG: 2268), a joint venture between Wuxi Biologics (HKG: 2269) and WuXi STA,...
Suzhou Acumen Biomedical Secures $13.8 Million in Series A+ Funding Round
China’s Suzhou Acumen Biomedical Technology Co., Ltd. has reportedly raised close to RMB 100 million...
Canton Biologics Secures Over RMB 300 Million in Series C Financing for Expansion
Canton Biologics Co., Ltd, a Guangzhou-based Contract Development and Manufacturing Organization (CDMO) specializing in biologic...
Shanghai Haoyuan Chemexpress Aims to Raise RMB 1.16 Billion with Convertible Bonds
China-based Contract Development and Manufacturing Organization (CDMO) Shanghai Haoyuan Chemexpress Co., Ltd (SHA： 688131) has...
iotaSciences Partners with Quantum Design China for Single-Cell Handling Platform Distribution
UK-based cell-line engineering firm iotaSciences has announced an exclusive partnership with Quantum Design China, a...
WuXi Biologics Reports 17.8% Revenue Growth and Expands Service Scope in H1 2023
China-based Contract Research, Development, and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) has released its...
Tigermed Establishes International Headquarters in Hong Kong to Accelerate Global Expansion
China-based Contract Research Organization (CRO) Tigermed (SHE: 300347, HKG: 3347) has announced the opening of...